WHO ICTRP trial
Study of chemotherapy for patients with good prognosis metastatic…
ISRCTN79658966 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN79658966 |
|---|---|
| Public title | Study of chemotherapy for patients with good prognosis metastatic non-seminomatous testicular cancer |
| Scientific title | Study of chemotherapy for patients with good prognosis metastatic non-seminomatous testicular cancer |
| Primary sponsor | Medical Research Council (MRC) (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | United Kingdom |
| Conditions | Cancer Cancer Testicular cancer |
| Interventions | Arm 1: Bleomycin 30 mg x 3 per course, BEP x 4 Arm 2: Bleomycin 30 mg per course, BEP x 4 |
| Registration date | Feb 28, 2001 |
| Target size | 44 |
| Secondary IDs | TE03 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: